Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognosticators for visual outcome in sarcoid uveitis

M R Dana1, J Merayo-Lloves, D A Schaumberg

  • 1Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston 02114, USA.

Ophthalmology
|November 1, 1996
PubMed
Summary

Identifying visual prognosticators in sarcoid-associated uveitis is crucial for patient care. Key factors influencing visual outcomes include delayed specialist presentation, disease duration, and specific uveitis types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.

British journal of cancer·2014
Same author

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.

Prostate cancer and prostatic diseases·2012
Same author

Atopic keratoconjunctivitis.

Ocular immunology and inflammation·2012
Same author

Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer.

British journal of cancer·2012
Same author

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

British journal of cancer·2012
Same author

Difluprednate for inflammatory eye disorders.

Drugs of today (Barcelona, Spain : 1998)·2011

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Sarcoid-associated uveitis is a complex intraocular inflammatory condition.
  • Understanding visual prognosticators is essential for managing patient outcomes under current care standards.

Purpose of the Study:

  • To identify visual prognosticators in sarcoid-associated uveitis.
  • To evaluate factors influencing visual rehabilitation in patients receiving standard care.

Main Methods:

  • Retrospective analysis of 60 patients with sarcoid-associated uveitis observed for at least 6 months.
  • Multivariate regression models (generalized estimating equations) used to adjust for inter-eye correlation.
  • Determination of disease, patient, and treatment characteristics impacting visual rehabilitation odds.

Related Experiment Videos

Main Results:

  • Factors associated with poorer visual acuity (<20/40) included delayed specialist presentation, longer uveitis duration, cystoid macular edema, glaucoma, intermediate/posterior uveitis, and systemic steroid use.
  • Black race and poorer presenting visual acuity were also linked to worse outcomes.
  • Despite complications, 34% of treated eyes and 51% of patients showed improved visual acuity from presentation.

Conclusions:

  • Multivariate outcomes analysis, accounting for fellow eye correlation, is valuable for optimizing care standards.
  • This analysis aids in disease risk stratification for both physicians and patients.
  • Identifying prognosticators can lead to improved management strategies for sarcoid-associated uveitis.